Stock-Sector Interview with NovaBay CEO Highlights Prospects for the Companys FDA-Cleared, Advanced Wound Cleanser, NeutroPhase(R), and its Development Pipeline - KTUL.com - Tulsa, Oklahoma - News, Weather & Sports

Stock-Sector Interview with NovaBay CEO Highlights Prospects for the Companys FDA-Cleared, Advanced Wound Cleanser, NeutroPhase(R), and its Development Pipeline

Posted: Updated:

New York, NY / ACCESSWIRE / March 5, 2014 / Stock-Sector.com, an online source of news about promising medical, technology and energy companies, today announced that it is releasing a video interview with Dr. Ron Najafi, Chairman and CEO of NovaBay Pharmaceuticals (NYSE: NBY), an Emeryville, CA biopharmaceutical company developing novel, topical, antimicrobial products.

In the interview, conducted at the recent BIO CEO & Investor Conference at the Waldorf-Astoria in New York City, Dr. Najafi described the upcoming milestones for NovaBay in 2014 — managing infections in wounds infected by flesh-eating bacteria with its FDA-cleared NeutroPhase and, on the development side, clinical trials in three conditions, including urinary catheter blockage and encrustation (UCBE) and viral conjunctivitis. NovaBay also expects to introduce its Advanced i-Lid CleanserTM, which cleans infected and irritated eyelids often associated with Belepharitis.

The recently-published study in the peer-reviewed journal WOUNDS demonstrated that NeutroPhase irrigation therapy and negative pressure wound therapy (NPWT) can be used for severe flesh eating and wound infections. “We believe that Crew-NovaBay Minimally Invasive Surgery for Necrotizing Fasciitis Using Adjunct NeutroPhase Therapy has the potential to continue to save lives and limbs,” said Dr. Ron Najafi, Chairman and Chief Executive Officer of NovaBay. NeutroPhase is 0.01% pure hypochlorous acid in saline with no bleach impurities, unlike other Dakin and Dakin-like solutions. Natural hypochlorous acid (HOCl) is produced by white blood cells. In extensive in-vitro testing, NeutroPhase kills bacteria in seconds and has the ability to neutralize toxins generated by flesh eating bacteria. NovaBay found a way to make pure HOCl in saline shelf-stable.

On the clinical development side, NovaBay is making progress in a variety of disease areas, including urinary catheter blockage and encrustation (UCBE). In September 2013, NovaBay reported positive phase 2 clinical study results of auriclosene to reduce urinary catheter blockage and encrustation (UCBE). Commented Dr. Najafi: “The positive, statistically-significant data from the Phase 2 clinical study of auriclosene to reduce UCBE confirms our belief that treating catheters with auriclosene can make a substantial difference in the lives of patients requiring chronic indwelling urinary catheters, including those with spinal cord injuries. We are excited to see that auriclosene may dramatically reduce the problems of unpredictable early catheter blockage.” NovaBay expects to commence the next phase 2 clinical trial in 2014”

NovaBay is also expecting the ongoing global clinical trial for auriclosene in conjunctivitis to complete with results available in the middle of 2014. The introduction of Advanced i-Lid Cleanser (being developed for use in ophthalmological applications) is expected in selected markets in 2014.

About NovaBay Pharmaceuticals – Going Beyond Antibiotics®

NovaBay Pharmaceuticals, Inc. (NYSE: NBY) is a clinical-stage biopharmaceutical company focused on addressing the unmet therapeutic needs of the global, topical anti-infective market with its Aganocide compounds, led by auriclosene. Auriclosene is a new chemical entity invented by NovaBay and has a broad spectrum of activity against bacteria, viruses and fungi. Aganocide compounds are based on the human body’s natural immune system and the molecules involved in combating infections. Bacterial resistance to Aganocides is highly unlikely, as demonstrated in in vitro studies. Once pathogens penetrate the body’s primary defense, the next line of defense is provided by the white blood cells. NovaBay has focused on understanding these molecules generated by the white blood cells and finding ways, by chemical modification, to allow them to be developed as therapeutic products with the potential to treat a wide range of local, non-systemic infections. NovaBay believes that if Aganocides® begin to supplement and thereby reduce the usage of classic topical antibiotics, they will help slow the rise of antibiotic resistance. For more information please visit: http://www.novabaypharma.com/.

About Stock-Sector.com

Stock-Sector.com is an online source of news about promising medical, technology and energy companies worldwide.

Article Here: www.stock-sector.com/index.php/medical/483-dr-ron-najafi-ceo-of-novabay-presents-at-bio-org-ceo-investor-conference-nyc-2014-nyse-nby

Video Here:

Contact: The Editor’s Desk | +1 855 459 4685 | info@Stock-Sector.com | http://stock-sector.com/

———————-

Disclaimer: This article may contain certain “forward-looking” statements and information relating to the companies mentioned herein that are based on the beliefs, assumptions and information currently available to each respective company’s management. Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security. Stock-Sector.com along with its owners, affiliates, subsidiaries, portfolio properties, officers, directors, representatives and agents may have received compensation for certain services related to this article. Please view our Terms, Policies and Compensation Disclosures at – www.WorldMarketMedia.com/terms-policies.

ReleaseID: 412708

  • NewsMore>>

  • Sorority Banned 5 Years For Hazing

    Sorority Banned 5 Years For Hazing

    Sorority Banned 5 Years For Hazing

    Northeastern State University has suspended a sorority for five years after a hazing investigation.More >>
    Northeastern State University has suspended a sorority for five years after a hazing investigation.More >>
  • Police Chief: Tahlequah Murder Victim Had Just Ended A Long Relationship

    Police Chief: Tahlequah Murder Victim Had Just Ended A Long Relationship

    Detectives in Tahlequah continue their investigation into the murder of an elderly woman.The body of 71-year-old beverly marshall was discovered inside her home on Thursday.She'd been shot four times.Police say a person of interest in the case was discovered dead Friday night.It's believed that person committed suicide.Police Chief Nate King says, they're "leaving no stone unturned"."Miss Marshall had been in a relationship for a very long time, and had recently ended that relationship. So th...More >>
    Detectives in Tahlequah continue their investigation into the murder of an elderly woman.The body of 71-year-old beverly marshall was discovered inside her home on Thursday.She'd been shot four times.Police say a person of interest in the case was discovered dead Friday night.It's believed that person committed suicide.Police Chief Nate King says, they're "leaving no stone unturned"."Miss Marshall had been in a relationship for a very long time, and had recently ended that relationship. So th...More >>
  • Report: Oklahoma's Young Adults #1 For Fast Food Spending

    Report: Oklahoma's Young Adults #1 For Fast Food Spending

    When it comes to making healthy food choices, Oklahoma's young people are getting a failing grade.According to a new survey by Level Money, Millennials in our state are number one nationwide when it comes to spending on fast food.Young adults in Oklahoma spent almost $1,200 a year when it comes to fast food.Experts say, it all boils down to education.Kaitlin Snyder with the Tulsa Health Department says, "It's easy for us to sit here and say that if you eat a certain number of fruits and veget...More >>
    When it comes to making healthy food choices, Oklahoma's young people are getting a failing grade.According to a new survey by Level Money, Millennials in our state are number one nationwide when it comes to spending on fast food.Young adults in Oklahoma spent almost $1,200 a year when it comes to fast food.Experts say, it all boils down to education.Kaitlin Snyder with the Tulsa Health Department says, "It's easy for us to sit here and say that if you eat a certain number of fruits and veget...More >>
Powered by WorldNow

P.O. Box 8 Tulsa, OK 74101-0008

Powered by WorldNow

All content © Copyright 2000 - 2014 Worldnow and KTUL. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.